N-(Methylcarbamoyl)acetamido N-methylcarbamate
CAS: 81424-67-1
Ref. 3D-GDA42467
25mg | 359.00 € | ||
250mg | 1,435.00 € |
Product Information
- (Acetyl-(methylcarbamoyl)amino) N-methylcarbamate
- Acetamide, N-((methylamino)carbonyl)-N-((methylamino)carbonyl)oxy)-
- Brn 5935912
- Caracemida
- Caracemida [Spanish]
- Caracemide [USAN:INN]
- Caracemidum
- Caracemidum [Latin]
- Ccris 1729
- N-((Methylamino)carbonyl)-N-(((methylamino)carbonyl)oxy)acetamide
- See more synonyms
- N-(Methylcarbamoyl)-N-(methylcarbamoyloxy)acetamid
- N-(methylcarbamoyl)-N-[(methylcarbamoyl)oxy]acetamide
- N-Acetyl-N,O-bis(methylcarbamoyl)hydroxylamine
- N-Acetyl-N,O-di(methylcarbamoyl)hydroxylamine
- N-Acetyl-N-(methylcarbamoyloxy)-N'-methylurea
- Nsc 253272
- Unii-H74F6J185A
N-(Methylcarbamoyl)acetamido N-methylcarbamate (NMCA) is a novel anti-cancer compound that selectively binds to the CB2 receptor. NMCA has been shown to inhibit the growth of cancer cells in vitro and in vivo, as well as reduce the size of bowel tumors. It also has a beneficial effect on cardiac function. The mechanism of action is not completely understood, but it may be due to binding to the CB2 receptor and blocking the activation of other receptors such as TNF-α. NMCA can be formulated into biocompatible polymers that are suitable for drug delivery. Furthermore, this compound can be used for treating inflammatory bowel disease and renal cell cancer.
Chemical properties
Technical inquiry about: 3D-GDA42467 N-(Methylcarbamoyl)acetamido N-methylcarbamate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.